Sudden unexpected death in epilepsy (SUDEP) is a serious and devastating, yet poorly understood outcome in epilepsy. This review discusses the current knowledge and understanding of SUDEP in children and adolescents. Established risk factors for SUDEP include history of generalized tonic-clonic seizures and nocturnal seizures. Other proposed risk factors include the use of multiple antiseizure medications and poor medication adherence. Possible prevention strategies for SUDEP include improved medication adherence, surgical interventions, nighttime safety, seizure detection devices, and diet. Pediatric providers have a great opportunity to educate families about SUDEP, assess medication adherence, and provide families with tools to improve medication adherence and learn about SUDEP in children and adolescents with epilepsy. Future research in SUDEP aims to further understand the etiology and risk factors of SUDEP, while developing more intervention strategies to prevent SUDEP.
Skip Nav Destination
Article navigation
REVIEW|
August 16 2021
Sudden Unexpected Death in Epilepsy (SUDEP): A Review of Risk Factors and Possible Interventions in Children
Justin W. Cole, PharmD
Correspondence. Justin W. Cole, PharmD; jwcole@cedarville.edu
Search for other works by this author on:
The Journal of Pediatric Pharmacology and Therapeutics (2021) 26 (6): 556–564.
Article history
Received:
August 28 2020
Accepted:
December 03 2020
Citation
Emily Wicker, Justin W. Cole; Sudden Unexpected Death in Epilepsy (SUDEP): A Review of Risk Factors and Possible Interventions in Children. The Journal of Pediatric Pharmacology and Therapeutics 1 September 2021; 26 (6): 556–564. doi: https://doi.org/10.5863/1551-6776-26.6.556
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionGet Email Alerts
Citing articles via
Comparison of Two Lipid Emulsions on the Incidence of Parenteral Nutrition Associated Cholestasis in Neonates
Joy Greenberg, PharmD<span class='al-author-delim'>, </span>Mamta Naik, RD, PharmD<span class='al-author-delim'>, </span>John Chapman, MD<span class='al-author-delim'>, </span>Allison Davidson, DO<span class='al-author-delim'>, </span>Essam Imseis, MD
Effect of a Pharmacist-Led Discharge Counseling Service at a Children's Hospital
Sara W. Hovey, PharmD<span class='al-author-delim'>, </span>Milica Misic, PharmD<span class='al-author-delim'>, </span>Jessica L. Jacobson, PharmD<span class='al-author-delim'>, </span>Kristen W. Click, PharmD
Low-Dose TMP-SMX for Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Solid Organ Transplant Recipients
Justin K. Chen, PharmD<span class='al-author-delim'>, </span>Jack Guerci, PharmD<span class='al-author-delim'>, </span>Heather Corbo, PharmD<span class='al-author-delim'>, </span>Marc Richmond, MD<span class='al-author-delim'>, </span>Mercedes Martinez, MD
Methylnaltrexone for Opioid-Induced Dysmotility in Critically Ill Infants and Children: A Pilot Study
Christina J. Smith, PharmD<span class='al-author-delim'>, </span>Caroline M. Sierra, PharmD<span class='al-author-delim'>, </span>Joanna Robbins, PharmD<span class='al-author-delim'>, </span>Nancy Y. Chang, PharmD<span class='al-author-delim'>, </span>Farrukh Mirza, MD
Implementation of a Shared Pediatric Pharmacy Elective During the COVID-19 Pandemic
Emily N. Israel, PharmD<span class='al-author-delim'>, </span>Chad A. Knoderer, PharmD